OG Shark Seeds represent a Canadian medical cannabis classic developed by Tweed Inc. in 2014 from a cross of Shark Shock and Great White Shark, producing an indica-dominant hybrid with an 80/20 genetic split. THC reaches 23 to 27 percent across documented batches, making it one of the most potent indica strains available in modern medical and recreational markets. Health Canada approved the cultivar for the ACMPR medical program, and patients use it widely for chronic pain, severe insomnia and treatment-resistant nausea. Feminized seeds with stabilized genetics deliver 8 to 9 week flowering cycles and yields of 500 to 650 grams per square meter indoors, ideal for both home cultivators and commercial medical operations.
OG Shark emerged in 2014 from the breeding program at Tweed Inc., one of Canada's pioneering licensed cannabis producers based in Smiths Falls, Ontario. The company developed the strain specifically for the Canadian medical cannabis market, with the goal of producing a high-THC indica-dominant cultivar capable of addressing chronic pain and severe insomnia in pharmaceutical-grade quantities.
Health Canada included OG Shark among the early approved cultivars for medical distribution, and the strain quickly became a staple in the ACMPR patient program serving thousands of patients across all Canadian provinces. Clinical observations at pain management clinics in Quebec and Ontario documented consistent efficacy for neuropathic pain and treatment-resistant insomnia, accelerating physician acceptance of the cultivar.
Distribution expanded rapidly into legalized US markets after 2018, particularly in Colorado, California and Nevada where indica-dominant high-THC cultivars commanded premium dispensary shelf prices. OG Shark earned a reputation as a reliable medical workhorse rather than a recreational novelty, distinguishing it from many trendier strains in the contemporary cannabis catalog with shorter staying power.
International demand surged after 2019 as European medical cannabis programs in Germany, Portugal and the UK began accepting Canadian-bred genetics. Today OG Shark holds canonical status as a Canadian classic in the medical segment, with patient communities and physicians specifically recommending it for conditions where high THC and pronounced indica effects are clinically appropriate.
Shark Shock derives from the Skunk #1 and White Widow lineage that defined late-1990s European breeding excellence. As a parent strain, Shark Shock contributes high resin production, the indica-dominant structural framework and the resistance to common growing pathogens that makes the cultivar accessible to less experienced cultivators in medical home-grow programs.
Great White Shark adds bud density and the trichome coverage that visually distinguishes OG Shark from similar high-THC indica hybrids. The trichome layer is so dense and silvery that it visually resembles the rough skin of an actual shark, which gave the strain its name and continues to attract photo-driven attention on social media platforms today.
Combined stabilization through four breeding generations standardized THC content at 25 percent and above, alongside reinforcing the sedative effect that makes the cultivar reliable for sleep-focused medical applications. The genetic combination produces remarkable consistency across batches, which is essential for medical applications where patients depend on predictable dosing outcomes from session to session.
The stabilization of OG Shark followed a rigorous protocol typical of pharmaceutical-grade cannabis development. Each phase tested specific traits to ensure consistency across batches sold to medical patients who depend on predictable dosing and uniform effects from one harvest to the next.
Laboratory testing places OG Shark THC content consistently between 23 and 27 percent across documented batches, occasionally pushing the upper boundary in optimized cultivation environments. This positions OG Shark as one of the most potent indica-dominant hybrids available in modern medical and recreational markets without entering the unstable territory of strains testing above 30 percent.
CBD levels remain minimal at 0.1 to 0.5 percent, which is typical for high-THC medical cultivars where the therapeutic emphasis falls on THC-driven analgesia rather than CBD-mediated effects. Patients seeking significant CBD content typically pair OG Shark with separate high-CBD cultivars during the same treatment cycle to combine both pathways effectively.
CBG content reaches up to 1 percent, which is genuinely high for any modern hybrid strain. The elevated CBG contributes anti-inflammatory and neuroprotective properties relevant to chronic pain management beyond what THC alone can deliver. Trace CBN accumulates during extended curing beyond eight weeks, deepening the sedative finish that already defines the strain's effect profile.
The chemical profile remains remarkably stable across cultivation environments compared to many other premium strains in the same potency tier. Indoor LED, indoor HPS and greenhouse setups all produce results within 2 to 3 percent THC variance, giving patients and growers high confidence in batch-to-batch consistency for medical dosing applications throughout treatment cycles.
The complete chemical fingerprint of OG Shark explains both its medical reputation and its characteristic sensory profile. Each cannabinoid and terpene contributes specific roles that combine through the entourage effect to produce the strain's distinctive consumer experience.
The data below reflects average ranges measured across multiple batches grown under standardized indoor LED conditions in Canadian and Californian licensed facilities. These numbers represent realistic expectations rather than peak outliers from cherry-picked harvests displayed at promotional events.
| Compound | Concentration | Primary Effect |
|---|---|---|
| THC | 23 to 27 percent | Primary psychoactive driver, analgesia and sedation |
| CBD | 0.1 to 0.5 percent | Minimal modulation of THC intensity |
| CBG | 0.5 to 1.0 percent | Anti-inflammatory and neuroprotective support |
| Myrcene | 0.8 to 1.2 percent | Sedative depth and earthy aroma |
| Caryophyllene | 0.5 to 0.8 percent | Peppery notes and CB2 anti-inflammatory action |
| Limonene | 0.3 to 0.5 percent | Citrus brightness and mild mood elevation |
| Pinene | 0.2 to 0.4 percent | Pine freshness and slight cognitive balance |
OG Shark produces a complex aroma profile dominated by sweet freshly cut hay and warm grassland notes. Secondary aromas reveal spicy peppercorn, warm cedarwood and a faint diesel-fuel undertone characteristic of OG lineage strains, creating a multi-dimensional aromatic experience that rewards methodical appreciation rather than rapid consumption.
The flavor profile carries the same complexity into the smoking experience. The exhale delivers a citrus brightness with lemon peel notes and earthy tropical undertones that surface on the back palate. Smoke or vapor produces a dense creamy texture with a long persistent finish that reinforces the indica-dominant character of the cultivar throughout the experience.
Visually, properly finished OG Shark stands out on any dispensary shelf. Buds appear deep dark green with purple hues developing in cool finishing conditions, while the trichome coverage is so dense and silvery-white that it resembles shark skin under bright lighting. Long bright orange pistils contrast strikingly against the green-purple bud background, creating a premium appearance.
The trichome density produces a crystalline glitter under direct light that photographs beautifully and signals premium quality to dispensary customers. Commercial cultivators specifically time their harvests to capture peak trichome maturation when 20 percent of resin glands show amber tips, balancing maximum THC content with the sedative effects that begin to emerge as trichomes oxidize.
OG Shark displays distinctive visual characteristics that allow experienced consumers and growers to identify the cultivar at a glance. These features distinguish the strain from similar indica-dominant hybrids and serve as quality indicators when evaluating purchased flower from various producers.
OG Shark produces a fast onset of 5 to 10 minutes when smoked or vaporized. The initial effects appear as a light cerebral lift without the strong euphoria typical of sativa-dominant cultivars, signaling the indica dominance from the very first minutes of the session experience.
The peak effect arrives roughly 30 to 45 minutes after consumption, when the body component fully develops and dominates the experience. Total active duration runs 2.5 to 3.5 hours of clear potent effects followed by an additional 1.5 to 2 hours of residual relaxation before the experience fully fades to baseline.
The transition from cerebral to body-focused experience happens relatively quickly with OG Shark compared to balanced hybrids. Within 15 minutes of consumption, muscular relaxation becomes apparent across the shoulders, lower back and limbs. This rapid body engagement is one reason medical patients with chronic pain prefer this cultivar over slower-acting alternatives.
Higher doses above 0.5 grams produce pronounced couch-lock and significant sedation. The strain finishes with strong drowsiness that supports sleep transition naturally. Comedown is gentle without significant grogginess the next morning when consumed at appropriate doses, though larger sessions may produce some residual fog for 1 to 2 hours after waking.
OG Shark suits a specific recreational context emphasizing evening relaxation and comfort rather than active social engagement or physical activity. The strain rewards quiet sessions at home with familiar surroundings rather than novel environments or activities requiring sustained attention to detail.
Movie watching, listening to music and post-workout muscle relaxation rank among the optimal recreational uses. The strain enhances tactile and auditory perception while reducing motivation for physical activity. Appetite typically returns 60 to 90 minutes into the experience, making OG Shark a natural choice for evening meals followed by extended downtime sessions.
Medical patients have documented OG Shark effectiveness across numerous conditions, making it one of the most clinically utilized cultivars in the Canadian medical program. The combination of high THC, meaningful CBG content and the sedative terpene profile addresses multiple symptom categories simultaneously.
OG Shark presents intermediate cultivation difficulty accessible to growers with at least one or two completed cycles of experience. The strain shows strong natural resistance to mold and most common fungal pathogens, which reduces the consequences of environmental control mistakes during late flowering.
Nutrient sensitivity emerges around calcium and magnesium, with deficiencies appearing during late flowering if the feed schedule does not include adequate supplementation. The compact indica structure stays manageable at 80 to 120 centimeters tall indoors with short internodes that minimize the need for aggressive training during vegetation.
The vegetative period runs relatively short at 3 to 4 weeks before flowering can begin productively. Flowering completes in 8 to 9 weeks with a clear maturation peak at day 60 when trichome production reaches maximum density. Cool nighttime temperatures below 17 degrees Celsius during the final two weeks trigger pronounced purple coloration in select phenotypes.
The dense bud architecture demands attention to humidity control during flowering to prevent botrytis development inside the colas. Maintaining flowering humidity at 40 to 45 percent and ensuring adequate airflow through the canopy minimizes the risk that the strain's signature density would otherwise create.
OG Shark responds to environmental precision with notable yield and quality improvements. Dialing in the optimal environment requires attention to temperature, humidity, lighting, nutrient management and atmospheric CO2 levels across the cultivation cycle stages.
OG Shark presents predictable challenges that growers should anticipate and prevent proactively. Awareness of these issues allows preventive intervention rather than reactive damage control once symptoms become visible on the plants in late flowering stages.
Calcium deficiency during late flowering manifests as twisted new growth and brown leaf-tip burn, requiring CalMag supplementation at 1 ml per liter when the issue first appears. Botrytis risk in dense colas requires aggressive defoliation at weeks three and five plus rigorous air circulation throughout the canopy. Temperature swings exceeding 10 degrees Celsius between day and night stress the plants and reduce trichome quality, requiring climate control consistency for optimal output.
Yield expectations for OG Shark vary based on cultivation method and environmental optimization. The figures below represent realistic outcomes documented across multiple grow journals from licensed Canadian producers and home growers rather than theoretical maximums from highly specialized commercial facilities.
Indoor methods produce predictable per-square-meter yields, while outdoor and greenhouse setups deliver larger per-plant numbers in favorable climates. Hydroponic systems generally outperform soil for raw yield while soil preserves slightly richer terpene expression in the final flower output.
| Cultivation Method | Yield per Plant | Yield per m² | Flowering Time |
|---|---|---|---|
| Indoor SCROG with 600W LED | 120 to 180 grams | 500 to 600 grams | 8 to 9 weeks |
| Indoor SOG with 1000W HPS | 50 to 80 grams | 500 to 650 grams | 8 to 9 weeks |
| Hydroponic DWC system | 150 to 220 grams | 600 to 700 grams | 8 to 9 weeks |
| Coco coir with manual feeding | 120 to 180 grams | 550 to 650 grams | 8 to 9 weeks |
| Outdoor in moderate climate | 500 to 750 grams | Not applicable | Harvest early October |
| Greenhouse with supplemental light | 400 to 700 grams | Not applicable | 9 to 10 weeks |
Proper post-harvest handling determines whether the genetic potential of OG Shark translates into top-shelf finished flower. Drying for 10 to 14 days in controlled conditions at 18 to 20 degrees Celsius and 55 to 60 percent humidity preserves terpenes while reducing moisture to the appropriate range for safe curing.
Curing in airtight glass jars for four to eight weeks transforms the harsh fresh-dried flower into smooth premium product. Daily burping during the first two weeks releases trapped moisture and ammonia byproducts of chlorophyll breakdown, preventing the hay-like flavor that ruins improperly cured cannabis batches from inexperienced cultivators.
Long-term storage beyond two months benefits from Boveda humidity packs at 62 percent inside vacuum-sealed bags or large glass jars. Storage at 15 to 20 degrees Celsius in complete darkness prevents UV-induced THC degradation, which can reduce potency by up to 16 percent annually under poor storage conditions exposed to ambient light and temperature swings.
The strain maintains peak freshness for approximately 12 months when stored correctly. Beyond that window, THC slowly converts to CBN, shifting the experience toward heavier sedation. Some medical patients deliberately age their OG Shark for three to four months specifically to deepen the sedative profile for sleep-focused applications during the period.
Sourcing authentic OG Shark genetics requires careful selection of a reputable seedbank. Many vendors sell inferior look-alike strains under the OG Shark name, which is why provenance verification matters before any purchase from any vendor claiming to offer this Canadian classic cultivar.
OG Shark shares its medical-grade reputation, indica-dominant effects and high-THC profile with several other premium strains in our catalog. If you appreciate the Canadian classic genetics and the sedative body-focused experience, the following cultivars offer complementary alternatives worth exploring for your collection.
We've reserved a special discount on your first SEEDS order — but it expires soon.